Ticker
PACBCompany Name
PACIFIC BIOSCIENCES OF CALIFORNIA INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 33.38M | 21.38% | $ 156.11M |
3/31/2025 | $ 24.63M | 16.17% | $ 152.36M |
12/31/2024 | $ 37.28M | 24.21% | $ 154.01M |
9/30/2024 | $ 36.8M | 21.25% | $ 173.15M |
6/30/2024 | $ 44.69M | 23.66% | $ 188.87M |
3/31/2024 | $ 54.3M | 27.09% | $ 200.43M |
12/31/2023 | $ 52.78M | 26.32% | $ 200.52M |
9/30/2023 | $ 48.35M | 28.52% | $ 169.52M |
6/30/2023 | $ 43.99M | 30.1% | $ 146.14M |
3/31/2023 | $ 44.64M | 33.31% | $ 134.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for PACIFIC BIOSCIENCES OF CALIFORNIA INC is calculated as follows: GP [ $ 34.1M ] / Revenues [ $ 79.69M ]
(=) Gross % [ 42.79% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.09% |
median | 49.46% |
std | 31.59% |